Q32 Share Price
NASDAQ: QTTB | Micro Cap | HealthcareQ32 Stock Performance
Q32 Share Price Today
As of 21 November 2026, Q32 Bio Inc.'s share price is $8.36. The stock opened at $8.30, compared to its previous close of $8.48. During today's trading session, Q32 Bio Inc.'s share price traded between $8.22 and $8.56, with an average price of $8.39. Over the past 52 weeks, the stock has recorded a high of $23.38 and a low of $1.92. In terms of performance, Q32 Bio Inc.'s share price has declined by 24.48% over the last six months and is up 283.49% on a year-on-year basis.
Q32 Share Price Chart
Q32 Quarterly Profit & Loss
All figures in USD
Q32 Annual Profit & Loss
All figures in USD
Q32 Balance Sheet
All figures in USD Million
Q32 Cash Flow
All figures in USD Million
About Q32
Q32 Bio Inc is a clinical-stage biotechnology company focused on developing novel biologics to restore healthy immune balance in patients with alopecia areata (AA) and other autoimmune and inflammatory diseases driven by immune dysfunction. Its product candidate, bempikibart (ADX 914), is a fully human anti-interleukin 7 receptor alpha (IL-7R) antagonist monoclonal antibody designed to block signaling mediated by interleukin 7 (IL 7) and thymic stromal lymphopoietin (TSLP) and re-regulate adaptive immune function. The company has completed two Phase 2a clinical trials evaluating bempikibart, SIGNAL AA Part A for the treatment of alopecia areata and SIGNAL AD for the treatment of atopic dermatitis (AD).
Q32 Historical Returns
| Month | Open | Close | Change % |
|---|---|---|---|
Nov 2026 | $8.78 | $8.36 | -6.75% |
Oct 2026 | $8.36 | $8.96 | +8.67% |
Sep 2026 | $14.49 | $8.25 | -48.93% |
Aug 2026 | $15.06 | $16.16 | +3.13% |
Jul 2026 | $12.72 | $15.66 | +22.77% |
Jun 2026 | $11.81 | $12.76 | +15.27% |
May 2026 | $5.46 | $11.07 | +95.58% |
Apr 2026 | $6.61 | $5.66 | -11.01% |
Mar 2026 | $4.80 | $6.36 | +39.17% |
Feb 2026 | $3.95 | $4.57 | +15.70% |
Jan 2026 | $3.28 | $3.95 | +20.43% |
Dec 2025 | $4.24 | $3.28 | +50.46% |